A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]

BACKGROUND: Complicated intra-abdominal infections (cIAI) remain challenging to treat because of their polymicrobial etiology including multi-drug resistant bacteria. The efficacy and safety of tigecycline, an expanded broad-spectrum glycylcycline antibiotic, was compared with imipenem/cilastatin (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliva, María E, Rekha, Arcot, Yellin, Albert, Pasternak, Jacyr, Campos, Maria, Rose, Gilbert M, Babinchak, Timothy, Ellis-Grosse, Evelyn J, Loh, Evan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277826/
https://www.ncbi.nlm.nih.gov/pubmed/16236177
http://dx.doi.org/10.1186/1471-2334-5-88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277826/
https://www.ncbi.nlm.nih.gov/pubmed/16236177
http://dx.doi.org/10.1186/1471-2334-5-88

Ejemplares similares